Medicare Advantage plans

Search documents
GoHealth Secures Amended Credit Agreement Highlighting Broad Based Support from Stakeholders
Globenewswire· 2025-06-30 20:30
CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace, today announced it has entered into an amendment with its lenders under the Company’s existing credit agreement in order to, among other things, provide covenant adjustments as well as extend the maturity of the Company’s revolving credit facility through September 30, 2025. The amendment also provides consent for the Company to pursue a receivables financing (such consent also covering a securi ...
Clover Health Set to Join Russell 3000® Index
Globenewswire· 2025-06-30 12:30
WILMINGTON, Del., June 30, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), announced that it is set to join the broad-market Russell 3000® Index, effective after the US market opens today, June 30, 2025, as part of the 2025 Russell indexes reconstitution. Annual reconstitution of the Russell indexes captures the 4,000 largest US stocks as of April 30, 2025, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place f ...
Humana (HUM) 2025 Investor Day Transcript
2025-06-16 19:00
Humana (HUM) 2025 Investor Day June 16, 2025 02:00 PM ET Speaker0 Ladies and gentlemen, welcome to Louisville, Kentucky for Humana's twenty twenty five Investor Day. Please welcome to the stage Lisa Stoner, Vice President of Investor Relations. Speaker1 Great. Good afternoon. Welcome to Humana's twenty twenty five Investor Conference. We really appreciate you all joining today. It is great to see so many familiar faces here in the room. And thank you to everyone that's joining us virtually. Over the next th ...
Options Traders Target UnitedHealth Stock Despite Steep 2025 Losses
Schaeffers Investment Research· 2025-06-02 15:42
UnitedHealth saw a surge in options volume over the last 10 trading daysShares of UnitedHealth Group Inc (NYSE:UNH) are struggling in 2025, down 39.1% year-to-date. Soaring medical costs -- especially within its Medicare Advantage plans -- and the surprise exit of CEO Andrew Witty have weighed heavily on the healthcare giant. But despite the turmoil, options traders are staying active.UNH just reappeared on Senior Quantitative Analyst Rocky White's list of equities with the highest options volume over the p ...
UnitedHealth Spirals Downward Amid New Criminal Probe: Time to Sell?
ZACKS· 2025-05-15 15:10
UnitedHealth Group Incorporated (UNH) is facing a wave of challenges, with little room to catch a break. The latest blow? A criminal investigation into possible Medicare fraud was reported by the Wall Street Journal. This comes on the heels of a disappointing first-quarter performance, where the company missed both earnings and revenue estimates. Rising costs, primarily tied to Medicare Advantage plans and the Optum health services segment, and higher utilization trends, are weighing heavily on margins.In a ...
SelectQuote (SLQT) Faces Investor Scrutiny After DOJ Alleges False Claims Act Violations - Hagens Berman
Prnewswire· 2025-05-09 12:21
SAN FRANCISCO, May 9, 2025 /PRNewswire/ -- On May 1, 2025, investors in SelectQuote (NYSE: SLQT) saw the price of their shares tumble over 19% after the U.S. Department of Justice announced it had filed a lawsuit against the company, other insurance brokers, and three of the nation's largest health insurance companies, claiming violations of the False Claims Act. Hagens Berman urges SelectQuote investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowled ...
SelectQuote (SLQT) Faces Investor Scrutiny After DOJ Alleges False Claims Act Violations – Hagens Berman
GlobeNewswire News Room· 2025-05-07 13:15
SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- On May 1, 2025, investors in SelectQuote (NYSE: SLQT) saw the price of their shares tumble over 19% after the U.S. Department of Justice announced it had filed a lawsuit against the company, other insurance brokers, and three of the nation's largest health insurance companies, claiming violations of the False Claims Act. Hagens Berman urges SelectQuote investors who suffered substantial losses to submit your losses now. The firm also encourages persons with kn ...
Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance
Globenewswire· 2025-05-06 20:05
First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-yearFirst quarter 2025 Total revenues of $462 million, up 33% year-over-yearMedicare Advantage medical costs are in line with expectations, underscoring the strength of Clover’s technology-first care management modelMeaningful improvement across first quarter 2025 profitability metrics: GAAP Net loss of $1 million, as compared to a GAAP Net loss of $19 million a year agoAdjusted EBITDA of $26 million, up 279% year-over-yearAdjuste ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
Prnewswire· 2025-05-06 18:04
NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Humana and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On May 1, 2025, the U.S. Department of ...
Alignment Healthcare(ALHC) - 2025 Q1 - Earnings Call Transcript
2025-05-01 22:02
Alignment Healthcare (ALHC) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants John Kao - Founder & CEOThomas Freeman - CFORyan Daniels - Group Head–Healthcare Technology and ServicesJohn Ransom - Managing Director, Director of Healthcare ResearchWhit Mayo - Senior Managing DirectorAndrew Mok - Director Conference Call Participants Michael Ha - Senior Research AnalystJessica Tassan - Senior Equity Research AnalystJoanna Gajuk - AnalystMatthew Gillmor - Director & Equity Research AnalystJona ...